Skip to main content
S&P 5007,580.07-1.82%DOW51,770.31-1.09%NASDAQ25,437.00-2.86%BTC$77,415.00+0.36%ETH$2,246.32+1.22%GOLD$3,884.90-3.63%OIL$102.95+0.93%
Smart Investors Daily
SID Premium
ML

NASDAQ · MLSS

Milestone Scientific Inc.

Healthcare · Medical - Instruments & Supplies

$0.30

Down-$0.01 (-3.30%)

Updated Nov 2, 2026, 9:19 AM

SID Score

4.5/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
28.42M
P/E ratio
-4.46
Dividend yield
0.00%
52-week range
$0.22 – $0.58
Volume
41.99K
Avg. volume
1.16M

Price performance · MLSS

MLSS price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 30, 2026

MLSS closed at $0.30 after 20 trading sessions, down 15.86% for the selected period.

Last close
$0.30
Period change
-15.86%
Period low
$0.30
Period high
$0.37
Daily close
View OHLC price history
MLSS OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 30, 2026$0.33$0.33$0.3003$0.304641.99K
Oct 29, 2026$0.3155$0.33$0.3011$0.315263.51K
Oct 28, 2026$0.307$0.3275$0.29$0.3167193.98K
Oct 27, 2026$0.3035$0.3225$0.30$0.3042.19K
Oct 26, 2026$0.30$0.33$0.2851$0.3025110.96K
Oct 23, 2026$0.301$0.3178$0.285$0.30548.95K
Oct 22, 2026$0.315$0.3208$0.3021$0.3115150.74K
Oct 21, 2026$0.325$0.3395$0.3071$0.31129.2K
Oct 20, 2026$0.3327$0.3409$0.3202$0.338195.65K
Oct 19, 2026$0.3239$0.3527$0.3239$0.33310.77K
Oct 16, 2026$0.325$0.361$0.32$0.326543.58K
Oct 15, 2026$0.3385$0.3429$0.3205$0.326747.35K
Oct 14, 2026$0.34$0.34$0.3277$0.338679.59K
Oct 13, 2026$0.337$0.3467$0.3201$0.3440.06K
Oct 12, 2026$0.34$0.35$0.30$0.348138.59K
Oct 9, 2026$0.36$0.3751$0.3475$0.3557.69K
Oct 8, 2026$0.38$0.38$0.351$0.3670.55K
Oct 7, 2026$0.377$0.3785$0.3601$0.3738.71K
Oct 6, 2026$0.3591$0.39$0.3522$0.3671127.53K
Oct 5, 2026$0.371$0.40$0.351$0.362277.47K

Latest MLSS news

The latest Smart Investors Daily articles mentioning MLSS.

Stock researchCompany · Overview

MLSS research

Overview

Company profile and research snapshot.

Company profile

Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$4.00
Implied upside
—
Analysts
8
MLSS recent ratings
DateFirmRatingTarget
Nov 20, 2025BenchmarkSpeculative Buy—
Nov 20, 2024BenchmarkSpeculative Buy—
Oct 10, 2024BenchmarkSpeculative Buy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 29, 2026

Milestone Scientific Provides Major Commercial Growth Update as CompuFlo® Expands Across 30 Million+ Annual Global Epidural Procedures

Company Reports 500+ U.S. Leads, Expanding Healthcare Network Relationships, Federal Market Access, International Distribution and 300+ Issued and Pending Patents Worldwide Just 2% Penetration of Estimated U.S. Epidural Procedure Market Represents $33 Million in Potential Annual Disposable Revenue Medical Segment Revenue Increased 200%+ in Q2 2026 as Company Advances Commercial Expansion and Recurring Revenue Strategy ROSELAND, N.J., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (N

Yahoo · Sep 29, 2026

Milestone Scientific Highlights Building a Scalable Growth Platform for CompuFlo® Medical Business

CompuFlo Builds Momentum as Physician Adoption, Reimbursement Access, Commercial Coverage and Clinical Evidence ExpandROSELAND, N.J., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a medical technology company specializing in advanced computerized injection and drug-delivery technologies, today highlighted continued progress in building a structured and scalable growth platform for its CompuFlo® medical business. “We are building CompuFlo into a scalable medi

Yahoo · Sep 16, 2026

Milestone Scientific Announces Pain and Spine Specialists and Dr. Sudhir Rao as CompuFlo® Development Partner and Advisor

Collaboration with leading 22-location interventional pain practice supports Milestone’s longer-term reimbursement strategyROSELAND, N.J., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery and injection technologies, today announced that Sudhir Rao, M.D., Medical Director of Pain and Spine Specialists, and Pain and Spine Specialists have joined Milestone Scientific as a development partner and member of the Compa

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By